| Project/Area Number |
24790051
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Physical pharmacy
|
|---|
| Research Institution | Tokyo University of Pharmacy and Life Science |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2014: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
|---|
| Keywords | 尿酸 / 尿酸トランスポーター / 蛍光タンパク質 / 腎臓 / 高尿酸血症 / トランスポーター / ウリカーゼ / 蛍光 / 蛍光プローブ |
|---|
| Outline of Final Research Achievements |
Serum urate level is strictly regulated by renal urate reabsorption and secretion through the urate transporters. In this study, it was aimed to develop a high-throughput biosensing method for analysis of urate transporter. A fusion protein consisted of uricase and hydrogen peroxide-dependent fluorescent protein (HyPer) was constructed. Since uricase produces hydrogen peroxide when oxidizes urate, the fusion protein could detect real-time urate uptake with fluorescence.
Monkey renal epithelial-like Cos7 cells were co-transfected with fusion protein and urate transporter 1 (URAT1), and incubated 48 hours. The fusion protein/URAT1 co-transfected cells showed the significant increase of fluorescence when 15-200 micro M of urate was applied. The fluorescence was suppressed with 25 micro M of benzbromarone, that was a URAT1 inhibitor.
In conclusion, the constructed uricase-HyPer fusion protein could detect urate uptake specifically.
|
